BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34924305)

  • 1. Pre-treatment neutrophil to lymphocyte ratio as a biomarker of frailty and predictor of survival among older adults with multiple myeloma.
    Giri S; Dahal S; Bal S; Godby KN; Richman J; Olszewski AJ; Williams GR; Brown C; Buford TW; Costa LJ; Bhatia S
    J Geriatr Oncol; 2022 May; 13(4):486-492. PubMed ID: 34924305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Pre-Treatment NLR and Other Hematologic Biomarkers on the Outcomes of Early-Stage Non-Small-Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy.
    Aduquaye M; Dube S; Bashir B; Chowdhury A; Ahmed N; Leylek A; Kim J; Lambert P; Bucher O; Hunter W; Sivananthan G; Koul R; Rathod S
    Curr Oncol; 2022 Jan; 29(1):193-208. PubMed ID: 35049693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frailty and inflammatory markers in older adults with cancer.
    Nishijima TF; Deal AM; Williams GR; Guerard EJ; Nyrop KA; Muss HB
    Aging (Albany NY); 2017 Mar; 9(3):650-664. PubMed ID: 28273043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation.
    Bojaxhiu B; Templeton AJ; Elicin O; Shelan M; Zaugg K; Walser M; Giger R; Aebersold DM; Dal Pra A
    Radiat Oncol; 2018 Nov; 13(1):216. PubMed ID: 30400969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline neutrophil-lymphocyte ratio holds no prognostic value for esophageal and junctional adenocarcinoma in patients treated with neoadjuvant chemotherapy.
    van Hootegem SJM; Smithers BM; Gotley DC; Brosda S; Thomson IG; Thomas JM; Gartside M; Barbour AP
    Dis Esophagus; 2020 Jun; 33(6):. PubMed ID: 31676907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Penile Squamous Cell Carcinoma Patients Undergoing Inguinal Lymph Node Dissection.
    Azizi M; Peyton CC; Boulware DC; Chipollini J; Juwono T; Pow-Sang JM; Spiess PE
    Eur Urol Focus; 2019 Nov; 5(6):1085-1090. PubMed ID: 29937330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated neutrophil-lymphocyte ratio predicts mortality following elective endovascular aneurysm repair.
    King AH; Schmaier AH; Harth KC; Kumins NH; Wong VL; Zidar DA; Kashyap VS; Cho JS
    J Vasc Surg; 2020 Jul; 72(1):129-137. PubMed ID: 32037083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Neutrophil-Lymphocyte Ratio and Frailty: The Chinese Longitudinal Healthy Longevity Survey.
    Xu W; Liang Y; Lin Z
    Front Med (Lausanne); 2021; 8():783077. PubMed ID: 35047530
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.
    Chai L; Cai K; Wang K; Luo Q
    J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited value of neutrophil-to-lymphocyte ratio and serum creatinine as point-of-care biomarkers of disease severity and infection mortality in patients hospitalized with COVID-19.
    Tufa A; Gebremariam TH; Manyazewal T; Asrat Y; Getinet T; Hundie TG; Webb DL; Hellström PM; Genet S
    PLoS One; 2022; 17(10):e0275391. PubMed ID: 36201435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neutrophil-to-lymphocyte ratio as a marker of vasculitis activity, severe infection and mortality in anca-associated vasculitis: A retrospective study.
    Fonseca JA; Gameiro J; Duarte I; Jorge S; Lopes JA
    Nefrologia (Engl Ed); 2021; 41(3):321-328. PubMed ID: 33309337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation markers are associated with frailty in elderly patients with coronary heart disease.
    Hou P; Xue HP; Mao XE; Li YN; Wu LF; Liu YB
    Aging (Albany NY); 2018 Oct; 10(10):2636-2645. PubMed ID: 30325739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma.
    Shi L; Qin X; Wang H; Xia Y; Li Y; Chen X; Shang L; Tai YT; Feng X; Acharya P; Acharya C; Xu Y; Deng S; Hao M; Zou D; Zhao Y; Ru K; Qiu L; An G
    Oncotarget; 2017 Mar; 8(12):18792-18801. PubMed ID: 27852046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association of platelet/lymphocyte ratio and neutrophil/lymphocyte ratio with protein-energy wasting in maintenance hemodialysis patients].
    Hu SS; Zhou CM; Li Q; Su FX; Chen S; Da JJ; Zha Y
    Zhonghua Yi Xue Za Zhi; 2019 Feb; 99(8):587-592. PubMed ID: 30818927
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of Neutrophil/Lymphocyte Ratio and Monocyte/Lymphocyte Ratio in the Prognosis of Patients with Multiple Myeloma].
    Yang WH; Sun YQ; Zhang QK; Wei XF; Li G
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Feb; 29(1):122-130. PubMed ID: 33554808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab.
    Capone M; Giannarelli D; Mallardo D; Madonna G; Festino L; Grimaldi AM; Vanella V; Simeone E; Paone M; Palmieri G; Cavalcanti E; Caracò C; Ascierto PA
    J Immunother Cancer; 2018 Jul; 6(1):74. PubMed ID: 30012216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frailty in Older Adults With Multiple Myeloma: A Study of US Veterans.
    Patel BG; Luo S; Wildes TM; Sanfilippo KM
    JCO Clin Cancer Inform; 2020 Feb; 4():117-127. PubMed ID: 32083955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of neutrophil-to-lymphocyte ratio for the fatality of COVID-19 patients complicated with cardiovascular diseases and/or risk factors.
    Higaki A; Okayama H; Homma Y; Sano T; Kitai T; Yonetsu T; Torii S; Kohsaka S; Kuroda S; Node K; Matsue Y; Matsumoto S
    Sci Rep; 2022 Aug; 12(1):13606. PubMed ID: 35948607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers.
    Li M; Spakowicz D; Burkart J; Patel S; Husain M; He K; Bertino EM; Shields PG; Carbone DP; Verschraegen CF; Presley CJ; Otterson GA; Kendra K; Owen DH
    J Cancer Res Clin Oncol; 2019 Oct; 145(10):2541-2546. PubMed ID: 31367835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Patients with Multiple Myeloma].
    Sun JY; Mu N; Mu J; Zhang CG; Wang DM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1185-1189. PubMed ID: 31418377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.